PCR AS
Score · fiscal year 2024
88of 100
How to read this: the company is ahead of 99 % of small companies in the same sector in 2024. What does this mean?
Rank: 31 of 3,976 · Sjømat
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 89 and solidity 98 out of 100 among small companies in the same sector in 2024. Methodology
Against the sector
PCR AS is 38 points above the median for small companies in the same sector in 2024.
Median score 50 among 3,476 companies.
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating margin | – | 3.7% |
| Profit margin | – | 0.8% |
| Return on assets | 19.8% | 1.2% |
| Equity ratio | 100.0% | 35.6% |
| Debt-to-equity | 0.00 | 0.96 |
| Current ratio | – | 1.52 |
| Revenue growth | – | −5.9% |
The median and “ahead of” refer to small companies in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 88, PCR AS does better than 99% of small companies in the same sector (3,481 companies) in 2024.
Score 2023–2025
- PCR AS
- Median: small companies in the same sector
What the numbers say
PCR AS had an operating margin of – and an equity ratio of 100.0% in 2024, and ranks 31 of 3,976 in Sjømat.
No large changes in the key figures from 2023 to 2024.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 2 MNOK and 4 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 4 MNOK |
| EV/EBIT | 8.0 | not meaningful |
| P/B | 1.0 | 2 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Data quality
- watch Revenue not reported
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of −5.0%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 89 | weight 30% |
|---|---|---|
| Solidity | 98 | weight 25% |
| Liquidity | – | no data, left out |
| Growth | – | no data, left out |
| Consistency | 70 | weight 15% |
Durability: 88 (average over 2 years)
Index version 2. Data completeness 70%: the share of the weights that had data.
Questions and answers
How profitable is PCR AS?
The operating margin was – in 2024, against a median of 3.7% among small companies in the same sector. Return on assets was 19.8%.
How solid is PCR AS?
The equity ratio was 100.0% in 2024 (median 35.6%). Debt-to-equity was 0.00 (median 0.96).
How does PCR AS compare in Sjømat?
PCR AS ranks 31 of 3,976 in Sjømat for 2024. Among companies of the same size (small companies) it ranks 25 of 3,481.
From the Central Coordinating Register
- Org. no.
- 929535278
- Legal form
- AS
- Sector
- Sjømat (03.110)
- Size tier
- small
- Employees
- 0–4 (not registered)
- Founded
- 1 July 2022 4 years in operation
- Share capital
- 0.40 MNOK
- Business address
- Remøy 66, 6094 LEINØY (HERØY)
- Municipality
- Herøy (Møre og Romsdal) rank 5–23 of 40 in KOSTRA group 1
- Audit
- Audit opted out from 22 July 2022
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Pål Cato Reite
- Chair of the board
- Pål Cato Reite
- Accountant
- AIDER AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 27 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 88 | 88 | 88 | |
| Rank | 48 | 31 | 29 | |
| Operating margin | – | – | – | |
| Return on assets | 23.1% | 19.8% | 17.1% | |
| Equity ratio | 100.0% | 100.0% | 99.8% | |
| Current ratio | – | – | 598.46 | |
| Revenue growth | – | – | – |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 0.0 MNOK | – | – |
| Operating profit | −0.1 MNOK | 0.0 MNOK | 0.0 MNOK |
| Profit before tax | 0.4 MNOK | 0.4 MNOK | 0.4 MNOK |
| Net profit | 0.4 MNOK | 0.4 MNOK | 0.4 MNOK |
| Financial expenses | 0.0 MNOK | – | – |
| Total assets | 1.7 MNOK | 2.1 MNOK | 2.5 MNOK |
| Current assets | 1.6 MNOK | 2.0 MNOK | 2.5 MNOK |
| Equity | 1.7 MNOK | 2.1 MNOK | 2.5 MNOK |
| Retained earnings | 0.6 MNOK | 1.0 MNOK | 1.4 MNOK |
| Total liabilities | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Current liabilities | 0.0 MNOK | – | 0.0 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 27 October 2026, accounts id 5930765.
Further
Similar companies
- AS FLØMANN index 89, rank 27 · compare
- EMMA OVEDIE AS index 88, rank 28 · compare
- NORSK BIOAKVA AS index 88, rank 29 · compare
- VESTERFJORD AS index 88, rank 30 · compare
- CQ RESSURS AS index 88, rank 32 · compare